Industry: Service & Software
Published Date: 2026-01-05
Pages: 110 Pages
Report ld: 5503654
Request Sample
Customized Report
Oocyte Cryopreservation Market Size(US$)

CAGR 2026-2032
15.0%
Market Size,2032
USD 274
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Oocyte Cryopreservation was estimated to be worth US$ 104 million in 2025 and is projected to reach US$ 274 million, growing at a CAGR of 15.0% from 2026 to 2032.
Human oocyte cryopreservation (egg freezing) is a procedure to preserve a woman's eggs (oocytes).The eggs are extracted, frozen and stored. The intention of the procedure is that the woman may choose to have the eggs thawed, fertilized, and transferred to the uterus as embryos to facilitate a pregnancy in the future.
America is the largest region market with more than 75% market share in oocyte cryopreservation industry in Canada and USA regions. Top players are Prelude Fertility, CReATe Fertility Center, Anova Fertility, San Diego Fertility Center (SDFC), Extend Fertility, Shady Grove Fertility, Mayo Clinic, Reproductive Biology Associates, CCRM IVF, HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group), Kindbody, West Coast Fertility Centers etc.
The driving factors of the oocyte cryopreservation market mainly include the following aspects:
Technological progress: The continuous improvement and maturity of oocyte cryopreservation technology has improved the recovery rate and survival rate of frozen oocytes, thereby increasing the clinical application prospects of this technology and driving the development of the market.
Changes in fertility concepts: The changes in modern women's fertility concepts and the intensification of the trend of late marriage and late childbearing have led more and more women to choose oocyte cryopreservation technology to maintain fertility and provide guarantees for future fertility plans.
Growth in medical demand: With the improvement of medical standards and people's attention to reproductive health, more and more medical institutions and patients have begun to pay attention to oocyte cryopreservation technology, which has promoted the rapid development of the market.
Policy support: The support policies for assisted reproductive technology in some countries and regions, as well as the improvement of relevant laws and regulations, have provided a good policy environment for the development of oocyte cryopreservation technology.
This report provides a comprehensive view of the global market for Oocyte Cryopreservation, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Customer.
The Oocyte Cryopreservation market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Oocyte Cryopreservation.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the Oocyte Cryopreservation companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Customer, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Oocyte Cryopreservation revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Oocyte Cryopreservation revenue at the country level. It provides segmented data by Type and by Customer for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Oocyte Cryopreservation Product Introduction
1.2 Global Oocyte Cryopreservation Market Size Forecast (2021–2032)
1.3 Oocyte Cryopreservation Market Trends & Drivers
1.3.1 Oocyte Cryopreservation Industry Trends
1.3.2 Oocyte Cryopreservation Market Drivers & Opportunities
1.3.3 Oocyte Cryopreservation Market Challenges
1.3.4 Oocyte Cryopreservation Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Oocyte Cryopreservation Players Revenue Ranking (2025)
2.2 Global Oocyte Cryopreservation Revenue by Company (2021–2026)
2.3 Key Companies’ R&D and Operations Footprint and Headquarters
2.4 Key Companies Oocyte Cryopreservation Product Offerings
2.5 Key Companies General Availability (GA) Timeline for Oocyte Cryopreservation
2.6 Oocyte Cryopreservation Market Competitive Analysis
2.6.1 Oocyte Cryopreservation Market Concentration Rate (2021–2026)
2.6.2 Top 5 and Top 10 Global Companies by Oocyte Cryopreservation Revenue in 2025
2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Oocyte Cryopreservation revenue, 2025
2.7 Mergers & Acquisitions and Expansion
3 Segmentation Oocyte Cryopreservation Market Classification
3.1 Introduction by Type
3.1.1 Slow-cooling Method
3.1.2 Flash-freezing Process (Vitrification)
3.1.3 Global Oocyte Cryopreservation Sales Value by Type
3.1.3.1 Global Oocyte Cryopreservation Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global Oocyte Cryopreservation Sales Value, by Type (2021–2032)
3.1.3.3 Global Oocyte Cryopreservation Sales Value, by Type (%), 2021–2032
4 Segmentation by Customer
4.1 Introduction by Customer
4.1.1 25-30 Year Old Female
4.1.2 30-35 Year Old Female
4.1.3 35-40 Year Old Female
4.1.4 Others
4.2 Global Oocyte Cryopreservation Sales Value by Customer
4.2.1 Global Oocyte Cryopreservation Sales Value by Customer (2021 vs 2025 vs 2032)
4.2.2 Global Oocyte Cryopreservation Sales Value by Customer (2021–2032)
4.2.3 Global Oocyte Cryopreservation Sales Value by Customer (%), 2021–2032
5 Segmentation by Region
5.1 Global Oocyte Cryopreservation Sales Value by Region
5.1.1 Global Oocyte Cryopreservation Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Oocyte Cryopreservation Sales Value by Region (2021–2026)
5.1.3 Global Oocyte Cryopreservation Sales Value by Region (2027–2032)
5.1.4 Global Oocyte Cryopreservation Sales Value by Region (%), 2021–2032
5.2 North America
5.2.1 North America Oocyte Cryopreservation Sales Value, 2021–2032
5.2.2 North America Oocyte Cryopreservation Sales Value by Country (%), 2025 vs 2032
5.3 Europe
5.3.1 Europe Oocyte Cryopreservation Sales Value, 2021–2032
5.3.2 Europe Oocyte Cryopreservation Sales Value by Country (%), 2025 vs 2032
5.4 Asia Pacific
5.4.1 Asia Pacific Oocyte Cryopreservation Sales Value, 2021–2032
5.4.2 Asia Pacific Oocyte Cryopreservation Sales Value by Subregion (%), 2025 vs 2032
5.5 South America
5.5.1 South America Oocyte Cryopreservation Sales Value, 2021–2032
5.5.2 South America Oocyte Cryopreservation Sales Value by Country (%), 2025 vs 2032
5.6 Middle East & Africa
5.6.1 Middle East & Africa Oocyte Cryopreservation Sales Value, 2021–2032
5.6.2 Middle East & Africa Oocyte Cryopreservation Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Oocyte Cryopreservation Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Oocyte Cryopreservation Sales Value, 2021–2032
6.3 United States
6.3.1 United States Oocyte Cryopreservation Sales Value, 2021–2032
6.3.2 United States Oocyte Cryopreservation Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Oocyte Cryopreservation Sales Value by Customer, 2025 vs 2032
6.4 Europe
6.4.1 Europe Oocyte Cryopreservation Sales Value, 2021–2032
6.4.2 Europe Oocyte Cryopreservation Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Oocyte Cryopreservation Sales Value by Customer, 2025 vs 2032
6.5 China
6.5.1 China Oocyte Cryopreservation Sales Value, 2021–2032
6.5.2 China Oocyte Cryopreservation Sales Value by Type (%), 2025 vs 2032
6.5.3 China Oocyte Cryopreservation Sales Value by Customer, 2025 vs 2032
6.6 Japan
6.6.1 Japan Oocyte Cryopreservation Sales Value, 2021–2032
6.6.2 Japan Oocyte Cryopreservation Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Oocyte Cryopreservation Sales Value by Customer, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Oocyte Cryopreservation Sales Value, 2021–2032
6.7.2 South Korea Oocyte Cryopreservation Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Oocyte Cryopreservation Sales Value by Customer, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Oocyte Cryopreservation Sales Value, 2021–2032
6.8.2 Southeast Asia Oocyte Cryopreservation Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Oocyte Cryopreservation Sales Value by Customer, 2025 vs 2032
6.9 India
6.9.1 India Oocyte Cryopreservation Sales Value, 2021–2032
6.9.2 India Oocyte Cryopreservation Sales Value by Type (%), 2025 vs 2032
6.9.3 India Oocyte Cryopreservation Sales Value by Customer, 2025 vs 2032
7 Company Profiles
7.1 Prelude Fertility
7.1.1 Prelude Fertility Profile
7.1.2 Prelude Fertility Main Business
7.1.3 Prelude Fertility Oocyte Cryopreservation Products, Services, and Solutions
7.1.4 Prelude Fertility Oocyte Cryopreservation Revenue (US$ Million), 2021–2026
7.1.5 Prelude Fertility Recent Developments
7.2 CReATe Fertility Center
7.2.1 CReATe Fertility Center Profile
7.2.2 CReATe Fertility Center Main Business
7.2.3 CReATe Fertility Center Oocyte Cryopreservation Products, Services, and Solutions
7.2.4 CReATe Fertility Center Oocyte Cryopreservation Revenue (US$ Million), 2021–2026
7.2.5 CReATe Fertility Center Recent Developments
7.3 Anova Fertility
7.3.1 Anova Fertility Profile
7.3.2 Anova Fertility Main Business
7.3.3 Anova Fertility Oocyte Cryopreservation Products, Services, and Solutions
7.3.4 Anova Fertility Oocyte Cryopreservation Revenue (US$ Million), 2021–2026
7.3.5 Anova Fertility Recent Developments
7.4 San Diego Fertility Center (SDFC)
7.4.1 San Diego Fertility Center (SDFC) Profile
7.4.2 San Diego Fertility Center (SDFC) Main Business
7.4.3 San Diego Fertility Center (SDFC) Oocyte Cryopreservation Products, Services, and Solutions
7.4.4 San Diego Fertility Center (SDFC) Oocyte Cryopreservation Revenue (US$ Million), 2021–2026
7.4.5 San Diego Fertility Center (SDFC) Recent Developments
7.5 Extend Fertility
7.5.1 Extend Fertility Profile
7.5.2 Extend Fertility Main Business
7.5.3 Extend Fertility Oocyte Cryopreservation Products, Services, and Solutions
7.5.4 Extend Fertility Oocyte Cryopreservation Revenue (US$ Million), 2021–2026
7.5.5 Extend Fertility Recent Developments
7.6 Shady Grove Fertility
7.6.1 Shady Grove Fertility Profile
7.6.2 Shady Grove Fertility Main Business
7.6.3 Shady Grove Fertility Oocyte Cryopreservation Products, Services, and Solutions
7.6.4 Shady Grove Fertility Oocyte Cryopreservation Revenue (US$ Million), 2021–2026
7.6.5 Shady Grove Fertility Recent Developments
7.7 Mayo Clinic
7.7.1 Mayo Clinic Profile
7.7.2 Mayo Clinic Main Business
7.7.3 Mayo Clinic Oocyte Cryopreservation Products, Services, and Solutions
7.7.4 Mayo Clinic Oocyte Cryopreservation Revenue (US$ Million), 2021–2026
7.7.5 Mayo Clinic Recent Developments
7.8 Reproductive Biology Associates
7.8.1 Reproductive Biology Associates Profile
7.8.2 Reproductive Biology Associates Main Business
7.8.3 Reproductive Biology Associates Oocyte Cryopreservation Products, Services, and Solutions
7.8.4 Reproductive Biology Associates Oocyte Cryopreservation Revenue (US$ Million), 2021–2026
7.8.5 Reproductive Biology Associates Recent Developments
7.9 CCRM IVF
7.9.1 CCRM IVF Profile
7.9.2 CCRM IVF Main Business
7.9.3 CCRM IVF Oocyte Cryopreservation Products, Services, and Solutions
7.9.4 CCRM IVF Oocyte Cryopreservation Revenue (US$ Million), 2021–2026
7.9.5 CCRM IVF Recent Developments
7.10 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group)
7.10.1 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Profile
7.10.2 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Main Business
7.10.3 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Oocyte Cryopreservation Products, Services, and Solutions
7.10.4 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Oocyte Cryopreservation Revenue (US$ Million), 2021–2026
7.10.5 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Recent Developments
7.11 Kindbody
7.11.1 Kindbody Profile
7.11.2 Kindbody Main Business
7.11.3 Kindbody Oocyte Cryopreservation Products, Services, and Solutions
7.11.4 Kindbody Oocyte Cryopreservation Revenue (US$ Million), 2021–2026
7.11.5 Kindbody Recent Developments
7.12 West Coast Fertility Centers
7.12.1 West Coast Fertility Centers Profile
7.12.2 West Coast Fertility Centers Main Business
7.12.3 West Coast Fertility Centers Oocyte Cryopreservation Products, Services, and Solutions
7.12.4 West Coast Fertility Centers Oocyte Cryopreservation Revenue (US$ Million), 2021–2026
7.12.5 West Coast Fertility Centers Recent Developments
7.13 Ruizhimei
7.13.1 Ruizhimei Profile
7.13.2 Ruizhimei Main Business
7.13.3 Ruizhimei Oocyte Cryopreservation Products, Services, and Solutions
7.13.4 Ruizhimei Oocyte Cryopreservation Revenue (US$ Million), 2021–2026
7.13.5 Ruizhimei Recent Developments
8 Industry Chain Analysis
8.1 Oocyte Cryopreservation Value Chain
8.2 Oocyte Cryopreservation Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Cost Structure
8.3 Midstream Analysis
8.4 Downstream (Customer) Analysis
8.5 Sales Model and Sales Channelss
8.5.1 Oocyte Cryopreservation Sales Model
8.5.2 Sales Channels
8.5.3 Oocyte Cryopreservation Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Oocyte Cryopreservation market size was US$ 104 million in 2025 and is forecast to reach a readjusted size of US$ 274 million by 2032 with a CAGR of 15.0% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 97
USD 4250.00
(Single User License)
The global Oocyte Cryopreservation market was valued at US$ 104 million in 2025 and is anticipated to reach US$ 274 million by 2032, at a CAGR of 15.0% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 114
USD 2900.00
(Single User License)
The global Oocyte Cryopreservation market size was US$ 92 million in 2024 and is forecast to a readjusted size of US$ 242 million by 2031 with a CAGR of 15.0% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 93
USD 4250.00
(Single User License)
The global Oocyte Cryopreservation market is projected to grow from US$ 92 million in 2024 to US$ 242 million by 2031, at a CAGR of 15.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-08
Pages: 140
USD 4900.00
(Single User License)
The global market for Oocyte Cryopreservation was estimated to be worth US$ 92 million in 2024 and is forecast to a readjusted size of US$ 242 million by 2031 with a CAGR of 15.0% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 112
USD 3950.00
(Single User License)
The global market for Oocyte Cryopreservation was valued at US$ 92 million in the year 2024 and is projected to reach a revised size of US$ 242 million by 2031, growing at a CAGR of 15.0% during the forecast period.
Published Date: 2025-01-19
Pages: 90
USD 2900.00
(Single User License)
The global Oocyte Cryopreservation revenue was US$ 81 million in 2023 and is forecast to a readjusted size of US$ 213 million by 2030 with a CAGR of 15.0% during the review period (2024-2030).
Published Date: 2024-11-29
Pages: 113
USD 4350.00
(Single User License)
The global market for Oocyte Cryopreservation was estimated to be worth US$ 81 million in 2023 and is forecast to a readjusted size of US$ 213 million by 2030 with a CAGR of 15.0% during the forecast period 2024-2030.
Published Date: 2024-11-29
Pages: 104
USD 3950.00
(Single User License)
Valued at US$ 92 million in 2024, the global Oocyte Cryopreservation market is forecast to reach US$ 213 million by 2030, at a CAGR of 15.0% during the forecast period.
Published Date: 2024-11-29
Pages: 142
USD 4900.00
(Single User License)
The global market for Oocyte Cryopreservation was valued at US$ 81 million in the year 2023 and is projected to reach a revised size of US$ 213 million by 2030, growing at a CAGR of 15.0% during the forecast period.
Published Date: 2024-11-29
Pages: 90
USD 2900.00
(Single User License)
The global Oocyte Cryopreservation market size was US$ 104 million in 2025 and is forecast to reach a readjusted size of US$ 274 million by 2032 with a CAGR of 15.0% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 97
The global Oocyte Cryopreservation market was valued at US$ 104 million in 2025 and is anticipated to reach US$ 274 million by 2032, at a CAGR of 15.0% from 2026 to 2032.
Published: 2026-01-05
Pages: 114
The global Oocyte Cryopreservation market size was US$ 92 million in 2024 and is forecast to a readjusted size of US$ 242 million by 2031 with a CAGR of 15.0% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 93
The global Oocyte Cryopreservation market is projected to grow from US$ 92 million in 2024 to US$ 242 million by 2031, at a CAGR of 15.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-08
Pages: 140
The global market for Oocyte Cryopreservation was estimated to be worth US$ 92 million in 2024 and is forecast to a readjusted size of US$ 242 million by 2031 with a CAGR of 15.0% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 112
The global market for Oocyte Cryopreservation was valued at US$ 92 million in the year 2024 and is projected to reach a revised size of US$ 242 million by 2031, growing at a CAGR of 15.0% during the forecast period.
Published: 2025-01-19
Pages: 90
The global Oocyte Cryopreservation revenue was US$ 81 million in 2023 and is forecast to a readjusted size of US$ 213 million by 2030 with a CAGR of 15.0% during the review period (2024-2030).
Published: 2024-11-29
Pages: 113
The global market for Oocyte Cryopreservation was estimated to be worth US$ 81 million in 2023 and is forecast to a readjusted size of US$ 213 million by 2030 with a CAGR of 15.0% during the forecast period 2024-2030.
Published: 2024-11-29
Pages: 104
Valued at US$ 92 million in 2024, the global Oocyte Cryopreservation market is forecast to reach US$ 213 million by 2030, at a CAGR of 15.0% during the forecast period.
Published: 2024-11-29
Pages: 142
The global market for Oocyte Cryopreservation was valued at US$ 81 million in the year 2023 and is projected to reach a revised size of US$ 213 million by 2030, growing at a CAGR of 15.0% during the forecast period.
Published: 2024-11-29
Pages: 90
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now